Stroke is one of the most common causes of morbidity and mortality worldwide. Despite significant advances in acute treatment and secondary prevention, primary prevention remains crucial to prevent the first occurrence of stroke and its serious consequences. The “Guideline for the Primary Prevention of Stroke” of the American Heart Association (AHA) and American Stroke Association (ASA) was fundamentally revised in 2024, replacing the previous recommendations from 2014.
Autoren
- Tanja Schliebe
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Dermatoscopic findings of granulomatous diseases
Cutaneous sarcoidosis, necrobiosis lipoidica and granuloma anulare
- Clostridioides difficile infection: specific therapy
Importance of vancomycin and fidaxomicin has increased
- Study report
Asthma exacerbation risk in patients with a psychological comorbidity
- Neuropathies - CIDP
Differentiate chronic inflammatory demyelinating polyneuropathy (CIDP)
- Treatment of type 2 diabetes: paradigm shift continues
Cardiorenal organ protection is increasingly coming to the fore
- Semaglutide and tirzepatide in HFpEF and T2D/obesity
Prospect of improved cardiovascular prognosis
- Case report: alveolar sarcoidosis
Acute hypoxemic respiratory failure as initial manifestation
- "Swiss Health Care Atlas"